UK NICE to collaborate with Russian formulary committee
This article was originally published in Scrip
The National Institute for health and Clinical Excellencefor England and Wales and the formulary committee of Russia’s academy of medical sciences have signed a collaboration agreement to exchange experience and information in the development and introduction of formularies for medical treatments, standards and quality assessment indicators.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.